The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
117173896 11717389 6 F 2015 20160718 20151110 20160801 PER US-AMGEN-USASP2015118256 AMGEN 65.00 YR E F Y 0.00000 20160801 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
117173896 11717389 1 PS ENBREL ETANERCEPT 1 Subcutaneous 50 MG, EVERY WEEK U U 1062502 103795 50 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE /wk

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
117173896 11717389 1 Rheumatoid arthritis

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
117173896 11717389 Arthralgia
117173896 11717389 Condition aggravated
117173896 11717389 Cough
117173896 11717389 Discomfort
117173896 11717389 Drug dose omission
117173896 11717389 Drug effect incomplete
117173896 11717389 Dry skin
117173896 11717389 Exfoliative rash
117173896 11717389 Hypoaesthesia
117173896 11717389 Injection site extravasation
117173896 11717389 Injection site macule
117173896 11717389 Joint range of motion decreased
117173896 11717389 Joint swelling
117173896 11717389 Mobility decreased
117173896 11717389 Musculoskeletal discomfort
117173896 11717389 Musculoskeletal pain
117173896 11717389 Musculoskeletal stiffness
117173896 11717389 Nausea
117173896 11717389 Neck pain
117173896 11717389 Oropharyngeal pain
117173896 11717389 Pain in extremity
117173896 11717389 Rash macular
117173896 11717389 Rash pruritic
117173896 11717389 Urinary tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
117173896 11717389 1 201505 0